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Summary  Adults  with  congenital  heart  lesions  constitute  a  rapidly  growing  group  of  patients
with cardiovascular  disease.  This  nascent  demographic  phenomenon  is  creating  major  issues
concerning the  optimal  management  of  these  patients,  in  whom  sudden  death  and  progressive
heart failure  are  predominant  causes  of  death.  Ventricular  dyssynchrony  appears  to  be  very
common in  this  population  and  can  appear  early  in  the  history  of  the  disease.  Recently,  cardiac
resynchronization  therapy  (CRT)  has  emerged  as  a  potential  treatment  option  for  patients  with
congenital  heart  disease  (CHD).  In  this  paper,  we  review  the  clinical  evidence  for  the  role  of
CRT in  a  number  of  different  groups  of  patients  with  congenital  heart  lesions.  In  particular,  we
focus on  whether  there  is  a  plausible  mechanistic  role  for  CRT  and,  if  so,  whether  this  results  in
acute and  longer-term  beneﬁcial  effects.  We  conclude  that  CRT  shows  promise  as  a  potential
treatment  option  for  patients  with  CHD  and  ventricular  impairment,  but  larger  clinical  outcome
studies are  required  before  deﬁnitive  guidance  can  be  issued.
© 2011  Elsevier  Masson  SAS.  All  rights  reserved.MOTS  CLÉS
Cardiopathies
congénitales
Résumé  Les  pathologies  cardiaques  congénitales  de  l’adulte  représentent  une  nouvelle
population  de  patients  qui  ne  cesse  de  croître  et  qui  pose  des  problèmes  spéciﬁques  pour
leur prise  en  charge.  La  mort  subite  et  l’installation  progressive  de  l’insufﬁsance  cardiaque
chez ces  patients  jeunes  représente  un  des  challenges  majeur  en  termes  de  surveillance  et  de
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thérapeutique.  L’asynchronisme  est  fréquent  dans  ces  groupes  de  patients  et  apparaît  souvent
très précocement  dans  l’enfance.  La  stimulation  cardiaque  de  resynchronisation,  sur  le  modèle
de l’insufﬁsance  cardiaque  gauche  avec  bloc  de  branche  gauche,  est  proposée  depuis  quelques
années chez  les  enfants  ou  les  adultes  congénitaux  qui  souffrent  d’insufﬁsance  cardiaque.  Les
premiers travaux  ont  décrit  l’effet  positif  immédiat  de  la  resynchronisation  en  post  chirurgie
de cardiopathie  congénitale  sur  des  tableaux  de  dysfonction  ventriculaire  gauche.  Les  effets
a plus  long  terme  sont  limités  a  quelques  cas  isolés  de  patients  inclus  dans  de  rares  études
mono- ou  multicentriques  portant  sur  la  resynchronisation  dans  les  cardiopathies  congénitales.
Les informations  que  l’on  peut  tirer  de  ces  études  sont  convergentes  et  suggèrent  toutes  une
amélioration  clinique  et  échographique  de  la  resynchronisation  chez  ces  patients  avec  cepen-
dant des  différences  en  fonction  du  groupe  anatomique  et  fonctionnel  de  chacun  :  dysfonction
ventriculaire  avec  bloc  de  branche  droit,  ventricule  droit  systémique  ou  ventricule  unique.
Dans cette  revue  nous  étudions  pour  chaque  groupe  de  cardiopathie  le  rôle  de  l’asynchronisme
et ses  implications  sur  le  développement  de  l’insufﬁsance  cardiaque,  voire  des  arythmies
ventriculaires  et  rapportons  les  diverses  expériences  et  application  de  resynchronisation
publiées  dans  ces  populations.
© 2011  Elsevier  Masson  SAS.  Tous  droits  réservés.
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Cardiac  resynchronization  therapy  (CRT)  has  been  shown  to
be  a  useful  therapy  for  adult  patients  with  chronic  left  ven-
tricular  (LV)  failure  due  to  idiopathic  or  ischaemic  dilated
cardiomyopathy  and  electromechanical  dyssynchrony.  It  has
been  shown  to  improve  exercise  tolerance,  heart  failure
symptoms,  and  survival  [1—4]. In  both  European  [5]  and
North  American  [6]  guidelines,  CRT  is  a  class  I  (level  of  evi-
dence  A)  therapy  for  patients  with  an  LV  ejection  fraction
less  or  equal  to  35%  and  QRS  ≥  120  ms  who  remain  symp-
tomatic  (New  York  Heart  Association  [NYHA]  functional  class
III—IV)  despite  optimal  medical  treatment.
At  the  same  time,  the  evidence  is  mounting  that  conven-
tional  dual-chamber  pacing  might  have  detrimental  effects
[7,8].  Several  trials  have  shown  that  right  ventricular  (RV)
apical  pacing  has  deleterious  effects  on  LV  function,  most
likely  due  to  the  induction  of  LV  dyssynchrony  [7—9]. RV
pacing  has  also  been  shown  to  have  adverse  effects  on  LV
cellular  structure,  ventricular  geometry,  and  systolic  and
diastolic  function,  all  of  which  lead  to  an  adverse  haemody-
namic  response  [7—9].
In contrast  to  the  vast  experience  with  biventricular
stimulation  gathered  in  adults  with  acquired  LVdysfunction
[3,10,11],  the  safety  and  efﬁcacy  of  CRT  in  patients  with
congenital  heart  disease  (CHD)  and  RV  dysfunction  has  not
been  fully  established.  Evidence  is  limited  to  case  reports,
retrospective  analyses  of  heterogeneous  populations,  and
small  crossover  trials  conducted  in  the  immediate  postop-
erative  period  [12—17]. Although  preliminary  results  are
encouraging,  the  applications  of  CRT  in  patients  with  CHD,
and  the  mechanisms  by  which  it  might  be  therapeutic,
remain  unclear.
In this  article,  we  review  the  indications  and  technical
aspects  for  implantation  of  CRT  devices  in  patients  with
CHD.  We  evaluate  the  various  short-  and  intermediate-term
results  and  discuss  future  directions  of  biventricular  resyn-
chronization  in  patients  with  CHD.
c
d
t
as there a clinical need for cardiac
esynchronization therapy (CRT) in
ongenital heart disease (CHD)?
HD  is  the  most  prevalent  major  birth  defect,  and  currently
ffects  more  than  1%  of  children  [18,19]. As  a result  of  major
mprovements  in  surgical  techniques,  postoperative  care,
nd  medical  management  in  recent  years,  the  population  of
dults  with  repaired  CHD,  particularly  patients  with  complex
esions  [20], is  increasing.  The  growth  of  this  population  is
inear  [19]  and  the  mortality  rate,  at  least  in  the  early  adult
ears,  is  relatively  low  [21]. However,  this  nascent  demo-
raphic  phenomenon  is  creating  major  issues  concerning  the
ptimal  management  of  adults  with  CHD  [22].
Surgery  is  undoubtedly  the  cornerstone  of  treatment  for
he  majority  of  patients  with  CHD.  Good  short-  and  mid-
erm  results  are,  however,  tempered  by  later  complications,
ncluding  the  development  of  ventricular  dysfunction  and
udden  death.  The  prevention  of  ventricular  impairment  and
entricular  arrhythmias  has  now  become  one  of  the  most
mportant  challenges  we  face  in  the  management  of  grown-
p  congenital  heart  (GUCH)  patients.  RV  dysfunction  is  an
bject  of  growing  interest,  although  currently,  the  thera-
eutic  options  remain  limited.  Even  if  surgical  repair  has
pparently  restored  normal  architecture,  it  is  likely  that
ubtle  and  persistent  abnormalities  of  cardiac  or  extracar-
iac  structure  and  function  persist.  Additionally,  the  natural
istory  of  the  underlying  condition  and/or  the  development
f  complications  may  all  lead  to  the  development  of  heart
ailure  and/or  arrhythmias  even  after  many  years.
Cardiac  electromechanical  dyssynchrony  decreases
egional  loading,  contractile  work,  myocardial  blood  ﬂow,
nd  oxygen  consumption  in  the  early-activated  anterior
yocardium,  whereas  these  parameters  are  increased  in
he  late-activated  lateral  left  ventricle.  Asymmetrical
ontraction  resulting  from  an  intraventricular  conduction
elay  is  now  well  identiﬁed  as  an  independent  predic-
or  of  mortality  in  patients  with  heart  failure  due  to
cquired  cardiopathy.  In  GUCH  patients,  electromechanical
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yssynchrony  is  becoming  more  frequent  in  asymptomatic
atients,  either  progressively  or  early  after  surgery.  A  rela-
ionship  between  electrical  and  mechanical  dysfunction,  as
ell  as  a  link  between  myocardialremodelling,  rhythm  dis-
urbances,  and  electromechanical  dyssynchrony,  probably
xists.  The  results  from  a  small  number  of  studies  published
hus  far  have  been  encouraging.  They  indicate  that  patients
resenting  with  CHD  have  an  anatomic  substrate  that  is
menable  to  cardiac  pacing  therapy;  and  have  also  shown
ositive  effects  with  both  biventricular  and  RV  pacing
12—17,23].  However,  it  is  important  to  highlight  that  the
peciﬁc  treatment  approach  is  very  much  dependent  on
he  underlying  condition  being  treated.  Patients  with  CHD
re  a  heterogeneous  population  with  a  variety  of  different
esions  responsible  for  their  symptoms,  such  as  tetralogy  of
allot  (TOF),  single  ventricle,  and  systemic  right  ventricle.
n  the  next  part  of  this  manuscript,  we  review  the  current
vidence  for  the  use  of  CRT  in  each  of  these  groups.
ight ventricular (RV) impairment in
urgically corrected tetralogy of Fallot
TOF)
he  majority  of  patients  with  ischaemic  or  dilated  cardiomy-
pathy,  LV  systolic  dysfunction,  and  asynchrony  have  left
undle  branch  block  (LBBB)  morphologies  [3].  In  this  setting,
RT  improves  haemodynamics  and  bioenergetics  [24]. Right
undle  branch  block  (RBBB)  is  almost  invariably  present  on
he  electrocardiogram  after  surgical  repair  of  TOF.  The  prog-
ostic  importance  of  a  wide  QRS  is  clear,  as  is  the  high
orrelation  between  QRS  duration  and  the  risk  of  developing
entricular  arrhythmias  [25—27]. While  failure  of  the  right
eart  is  multifactorial,  caused  by  the  combined  effects  of
ressure  and  volume  overloads,  and  of  myocardial  lesions
nﬂicted  during  and  after  surgery,  the  haemodynamic  conse-
uences  of  this  electrical  anomaly  might  play  an  important
ole  in  the  long-term  clinical  outcomes  of  these  patients.
udden  death  and  progressive  heart  failure,  the  most  com-
on  causes  of  death  in  this  population  [26,28,29], may  be
romoted  by  the  remodelling  induced  by  mechanical  dyssyn-
hrony,  which  therefore  may  be  a  desirable  therapeutic
arget  [30,31].
RV  dysfunction  has  been  associated  with  a  prominent  RV
echanical  delay  in  a  porcine  model  that  emulated  some
f  the  mechanical  and  electrophysiological  abnormalities
bserved  in  TOF  [32]. Biventricular  stimulation  signiﬁcantly
mproved  the  function  of  both  ventricles,  measured  using
nvasive  haemodynamic  studies  and  echocardiography.  In
ontrast,  RV  stimulation  from  three  separate  sites  has
een  found  to  confer  no  functional  beneﬁt  over  intrin-
ic  conduction  [33]. While  this  model  reproduced,  albeit
mperfectly,  the  anatomical  and  electrophysiological  abnor-
alities  observed  in  patients  suffering  from  TOF,  it  is
oteworthy  that  RV  dysfunction  was  alleviated  by  cardiac
timulation.
Lumens  et  al.  have  observed  favourable  effects  with
timulation  of  the  RV  free  wall  in  a  computer  model  of  pul-
onary  hypertension  associated  with  RV  dysfunction  [34].
his  suggests  that,  in  the  presence  of  pulmonary  arterial
ypertension,  stimulation  of  the  RV  free  wall  can:  allevi-
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te  the  heavy  overload  imposed  on  that  wall;  equalize  the
oad  conditions  and  amplitudes  of  segmental  contraction;
nd  increase  RV  contractility.
cute effects of cardiac stimulation
he  immediate  haemodynamic  effects  of  RV  or  biventricu-
ar  stimulation  in  adults  presenting  with  TOF,  RV  dysfunction,
nd  a  wide  QRS  have  been  examined  in  two  studies  [14,33].
n  the  study  by  Dubin  et  al.,  seven  patients  (six  suffering
rom  TOF)  who  presented  with  isolated  RV  dysfunction  and
BBB  underwent  haemodynamic  investigation  [14]. Transve-
ous  pacing  catheters  were  positioned  in  the  right  atrium
nd  ventricle.  The  atrioventricular  (AV)  interval  was  pro-
rammed  to  90%  of  the  PR  interval.  A  number  of  different  RV
acing  sites  were  tested,  including  the  apex,  outﬂow  tract,
nd  septum.  Overall,  sequential  AV  pacing  improved  cardiac
utput  and  RV  dP/dt  and  decreased  QRS  duration  when  com-
ared  to  atrial  pacing  alone  and  normal  sinus  rhythm  [14].
he  site  that  optimized  QRS  duration  did  not  correlate  with
he  one  yielding  optimal  RV  function.  There  was,  however,  a
trong  relationship  between  the  degree  of  QRS  improvement
nd  the  observed  increase  in  cardiac  output.
In  our  study  of  eight  adults  who  presented  with  repaired
OF,  RV  and  LV  dP/dtmax were  measured  invasively  during:
pontaneous  rhythm;  RV  apical  stimulation;  and  biventricu-
ar  stimulation  [33]. The  AV  delay  was  programmed  at  70%
f  spontaneous  to  allow  complete  capture  of  both  ventri-
les.  The  mean  LV  ejection  fraction  was  signiﬁcantly  lower
han  in  a  control  population.  Single  RV  stimulation  increased
V  dP/dtmax,  but  did  not  increase  LV  dP/dtmax,  whereas
iventricular  stimulation  increased  the  contractility  of  both
entricles.  These  acute  studies  suggest  that  RV  pacing  may
e  beneﬁcial  in  patients  with  heart  failure  and  RBBB,  which
s  contrary  to  RV  pacing  for  bradycardia  in  the  presence  of
ormal  ventricular  function.  Conversely,  biventricular  stim-
lation  seems  preferable  in  presence  of  concomitant  LV
ysfunction.
cute postoperative setting
n  the  acute  postoperative  setting,  the  failing  ventricle  has
raditionally  been  managed  by  inotropic  support.  With  most
notropic  agents,  contractility  is  enhanced  at  the  expense  of
ncreasing  myocardial  oxygen  consumption  and  energy  store
epletion  [35]. In  contrast,  in  patients  with  dilated  car-
iomyopathy  and  LBBB,  CRT  may  improve  cardiac  function
hile  modestly  diminishing  myocardial  energy  demand  [36].
ollowing  complex  congenital  heart  surgery,  both  AV  block
nd  intraventricular  conduction  delay  are  not  uncommon.
Initial  experience  with  CRT  in  CHD  has  focused  on  the
cute  postoperative  setting.  The  immediate  postoperative
ffects  of  CRT  were  initially  studied  in  mixed  populations  of
atients  presenting  with  CHD,  which  included  patients  with
OF  [13,37,38]. One  case  report  described  a  6-month-old
nfant  with  TOF  and  atresia  of  the  left  pulmonary  artery  in
hom  acute  epicardial  CRT  led  to  improved  LV  function  and
uccessful  weaning  from  extracorporeal  circulation  [39].
n  all  the  reports,  atrial  synchronized  RV  stimulation  with
ptimized  AV  delays  was  performed,  using  temporary  RV
ires  placed  during  the  operation.  Ventricular  stimulation
mmediately  increased  systemic  blood  pressure,  enabled  a
a
l
t
A
t
o
t
a
g
i
t
s
t
a
t
t
i
p
A
B
m
U
t
s
c
p
n
p
t
a
a
a
s
s
a
L
T
l
p
e
d
h
i
s
s
p
c
f
t
p
d
A
aResynchronization  in  congenital  heart  disease  
decrease  in  inotropic  support  and  volume  replacement,  and
stabilized  haemodynamic  function  during  the  ﬁrst  postoper-
ative  48  hours,  after  which  stimulation  could  be  uneventfully
discontinued.
Long-term ventricular pacing
Interpretation  of  long-term  clinical  results  of  CRT  in  TOF
patients  is  problematic  due  to  the  absence  of  dedicated
studies.  The  only  available  data  are  from  case  reports  or
studies  of  CRT  in  patients  suffering  from  CHD,  where  statis-
tical  analyses  did  not  distinguish  TOF  patients  from  patients
with  other  types  of  CHD.  The  ﬁrst  case  report  describing  the
application  of  CRT  in  a  TOF  patient  was  in  an  infant  who
developed  complete  AV  block  and  had  a  permanent  RV  pac-
ing  lead  implanted  at  the  time  of  surgery  [40]. The  patient
subsequently  developed  left  heart  failure  and  a  markedly
depressed  LV  ejection  fraction.  The  addition  of  an  LV  lead
was  followed  by  a  clear  clinical  improvement  and  his  LV
ejection  fraction  returned  to  normal.  As  well  as  the  positive
effect  of  CRT  in  TOF,  this  report  highlighted  the  importance
of  adapting  the  stimulation  mode  to  the  individual  patient
characteristics,  and  supports  the  use  of  biventricular  stim-
ulation  in  the  presence  of  concomitant  LV  dysfunction  due
to  RV  pacing.  Cecchin  et  al.  implanted  CRT  devices  into  six
patients  with  TOF  or  a  variant  of  the  disease  [41], while
the  study  by  Dubin  et  al.  included  11  such  patients  [14,41].
CRT  appeared  to  provide  clinical  beneﬁt  in  these  patients.
Additionally,  there  was  a  suggestion  that  the  TOF  patients
derived  a  greater  treatment  beneﬁt  from  CRT  than  patients
with  other  congenital  heart  lesions,  such  as  a  systemic  right
ventricle.
Summary
Patients  with  surgically  corrected  TOF  presenting  with  RV
failure  with  RBBB  potentially  have  a  substrate  that  is  suit-
able  for  treatment  with  cardiac  pacing.  Little  clinical  data
currently  exists,  but  acute  haemodynamic  studies  have
shown  improvements  with  RV  pacing,  and  the  small  number
of  patients  receiving  CRT  devices  appear  to  have  gained  clin-
ical  beneﬁt.  Further  clinical  studies  are  required  before  CRT
can  be  recommended  in  evidence-based  clinical  guidelines,
however,  it  does  show  promise  in  this  group  of  patients.
Single ventricle
The  term  ‘‘single  ventricle’’  encompasses  a  spectrum  of
complex  congenital  cardiac  anomalies  in  which  there  is  only
one  ventricle  to  pump  blood  to  the  pulmonary  and  systemic
vascular  beds.  This  group  of  disorders  includes  problems
such  as  tricuspid  valve  atresia,  hypoplastic  left-  or  right-
heart  syndromes,  mitral  valve  atresia,  and  double-inlet
ventricle.  The  development  of  a  number  of  innovative  oper-
ations,  including  the  Fontan  and  Norwood  procedures,  has
resulted  in  dramatic  improvements  in  outcomes.  However,
even  after  excellent  early  results,  single-ventricle  patients
undergoing  a  Fontan  operation  remain  at  risk  of  progressive
ventricular  dysfunction,  which  remains  the  leading  cause  of
death  in  this  population.  In  Fontan  patients  with  end-stage
myocardial  dysfunction,  heart  transplantation  has  tradition-
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lly  been  the  only  option  to  improve  survival.  However,  the
imited  donor  supply  and  the  high-risk  nature  of  transplan-
ation  demand  a  search  for  alternative  forms  of  treatment.
lthough  ventricular  impairment  in  Fontan  patients  appears
o  be  multifactoral,  CRT  has  been  suggested  as  a  treatment
ption.  In  at  least  a  proportion  of  patients  with  a  single  ven-
ricle  there  appears  to  be  a  substrate  that  is  potentially
menable  to  treatment  with  CRT.  Signiﬁcant  echocardio-
raphic  ventricular  dyssynchrony  has  been  demonstrated
n  these  patients  despite  a  limited  increase  in  QRS  dura-
ion  [42,43]. In  addition,  compared  with  controls,  operated
ingle  ventricle  patients  have  signiﬁcant  reductions  in  sys-
olic  and  diastolic  function  as  well  as  decreased  twisting
nd  circumferential  strain.  The  association  between  ven-
ricular  dysfunction  and  ventricular  dyssynchrony  suggests
hat  CRT  may  have  the  potential  to  produce  improvements
n  cardiac  function  in  some  patients  with  single  ventricle
hysiology.
cute postoperative setting
acha  et  al.  have  investigated  26  patients  (mean  age  28
onths)  who  underwent  single  ventricle  palliation  at  the
niversity  of  Chicago  Children’s  Hospital,  irrespective  of
heir  electrocardiographic  morphology  [44]. At  the  time  of
urgery,  two  atrial  and  three  ventricular  temporary  epi-
ardial  pacing  leads  were  placed.  The  objective  of  CRT  in
atients  with  a single  ventricle  is  intraventricular  resynchro-
ization  through  multisite  pacing,  rather  than  biventricular
acing.  In  this  study,  the  ventricular  leads  were  positioned
o  produce  an  equidistant  triangle,  with  corners  as  distant
s  possible.  Despite  having  a  narrow  QRS  (93.9  ±  17.5  ms)
t  baseline  prior  to  treatment,  CRT  was  associated  with
 signiﬁcant  decrease  in  QRS  duration  (71.7  ±  10.8  ms),  a
igniﬁcant  increase  in  cardiac  index  and  systolic  blood  pres-
ure,  and  a  signiﬁcant  decrease  in  ventricular  dyssynchrony
ssessed  by  3D  echocardiography.
ong-term ventricular pacing
here  have  been  two  case  reports  that  have  described  the
ong-term  impact  of  CRT  in  patients  with  single  ventricle
hysiology.  In  the  ﬁrst,  an  18-year-old  patient  with  an  inop-
rable  single  ventricle,  wide  baseline  QRS  duration,  and
epressed  ejection  fraction  was  repeatedly  hospitalized  for
eart  failure  [45]. One  atrial  and  two  ventricular  leads  were
mplanted,  with  one  ventricular  lead  on  the  right  side  of  the
ingle  ventricle  and  the  other  on  the  left  side.  CRT  induced
igniﬁcant  acute  improvement  in  terms  of  systolic  blood
ressure,  contractility,  stroke  work,  and  mechanical  efﬁ-
iency.  On  long-term  follow-up,  clinical  status  and  ejection
raction  were  also  signiﬁcantly  improved.
A  second  patient  underwent  a  hemi-Fontan  procedure  at
he  age  of  12  months,  followed  by  a  fenestrated  Fontan
rocedure  at  the  age  of  5  years,  with  implantation  of  a
ual-chamber  epicardial  pacemaker  for  iatrogenic  complete
V  block  [46]. This  patient  was  hospitalized  repeatedly
fter  the  procedure  because  of  progressive  heart  failure,
ith  demonstration  of  impaired  ventricular  function,  mitral
egurgitation,  and  wide-paced  QRS  duration.  At  the  age  of  11
ears,  he  underwent  positioning  of  two  supplementary  epi-
ardial  ventricular  leads.  Compared  with  baseline,  optimal
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ultisite  pacing  produced  an  almost  20%  increase  in  cardiac
utput.  Follow-up  at  3  months  showed  clear  clinical  beneﬁt
ith  improvement  in  ejection  fraction  and  ventricular  size.
Two  series  have  included  patients  with  single  ventri-
les  and  long-term  CRT.  In  a  multicentre  study  [16], seven
atients  with  a  single  ventricle  were  included.  The  results
n  these  patients  were  not  encouraging,  with  no  improve-
ents  in  ejection  fraction,  and  only  two  patients  obtaining
linical  improvements.  In  contrast,  the  impact  of  CRT  was
ound  to  be  much  more  promising  in  a  single-centre  study
41]  that  included  13  patients  with  a  single  ventricle.  They
eported  improvements  in  terms  of  NYHA  class  and  ejection
raction.  The  different  ﬁndings  in  these  two  studies  may  be
ue  to  differences  in  baseline  QRS  duration  and  pacing  site.
 particular  effort  was  made  in  the  single-centre  study  [41]
o  optimize  the  pacing  sites  and,  in  particular,  to  obtain
he  maximal  distance  between  the  two  ventricular  pacing
ites.
ummary
he  role  of  CRT  in  improving  outcomes  in  patients  with  a  sin-
le  ventricle  currently  remains  unclear.  Attempts  to  answer
his  question  may  have  been  hampered  by  the  fact  that
he  term  ‘‘single  ventricle’’  covers  a  broad  spectrum  of
omplex  congenital  anomalies.  Potentially,  these  different
athologies  may  behave  differently  when  CRT  is  applied.
election  of  appropriate  patients  and  the  technical  aspects
f  the  implant  procedure,  such  as  selecting  appropriate
ead  position,  may  be  dependent  on  the  particular  under-
ying  substrate.  At  ﬁrst  sight,  CRT  may  not  be  an  obvious
olution  for  treating  patients  with  ventricular  impairment
nd  a  single  ventricle,  as  they  typically  have  a  narrow
RS  duration.  However,  echocardiographic  studies  have  sug-
ested  that  at  least  a  proportion  of  patients  do  appear  to
xperience  mechanical  dyssynchrony,  and  some  investiga-
ors  have  obtained  promising  results  with  CRT  in  this  group  of
atients.
As  highlighted,  there  is  currently  limited  evidence
egarding  the  use  of  CRT  in  this  group  of  patients.  Further
linical  studies  are  therefore  clearly  necessary  before  CRT
an  be  recommended  in  clinical  guidelines  for  patients  with
 failing  single  left  ventricle,  though  it  may  be  considered
n  the  absence  of  other  treatment  options.
ystemic right ventricle
he  right  ventricle  is  systemic  in  congenitally  corrected  and
omplete  transposition  of  the  great  arteries.  The  majority  of
dults  with  complete  transposition  of  the  great  arteries  have
ad  atrial  switch  procedures  during  their  childhood.  Progres-
ive  RV  dysfunction  frequently  complicates  atrial  redirection
urgery,  in  which  the  right  ventricle  is  left  connected  to  the
ystemic  circulation.  The  right  ventricle  is  best  suited  to
unction  as  a  low-pressure  volume  pump,  rather  than  having
o  generate  high  pressures  and  face  high  resistance,  which
s  intrinsic  to  the  systemic  circulation.  In  patients  with  end-
tage  systemic  RV  dysfunction,  heart  transplantation  carries
 high  mortality,  and  current  advice  is  to  delay  or  avoid
his  whenever  possible.  Therefore,  identiﬁcation  of  novel
herapeutic  strategies  is  of  critical  importance.
c
d
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Failure  of  the  systemic  right  ventricle  may  be  partly
elated  to  ventricular  dyssynchrony.  A  wide  QRS  duration
>  120  ms)  has  been  observed  in  41%  of  patients  with  TGA
fter  intra-atrial  redirection  of  blood  and  in  37%  with
ongenitally  corrected  transposition  of  the  great  arteries
ccTGA)  [47]. Also,  Chow  et  al.  found  a  high  prevalence
f  RV  (32%)  and  inter-ventricular  (57%)  dyssynchrony  (using
issue  Doppler  echocardiography)  in  patients  with  com-
lete  transposition  after  Mustard  or  Senning  procedures
48]. Ventricular  dyssynchrony  was  associated  with  RV  sys-
olic  dysfunction  and  impaired  exercise  performance.  The
egional  differences  in  the  timing  of  RV  contraction  and
he  lack  of  myocardial  coordination  may  partly  explain  the
educed  pumping  function,  as  well  as  contributing  to  the
ncreased  prevalence  of  signiﬁcant  tricuspid  regurgitation
48]. Overall,  the  association  between  decreased  contrac-
ility  and  dyssynchrony  in  patients  with  systemic  RV  failure
rovides  a  rationale  for  the  use  of  CRT.
cute studies in the immediate postoperative
etting
anousek  et  al.  have  assessed  the  acute  haemodynamic
mpact  of  CRT  in  eight  patients  (aged  6—29  years)  with
 systemic  right  ventricle  and  RBBB  (n  =  2)  or  pacing  from
he  left  ventricle  (n  =  6)  [17]. CRT  was  associated  with
igniﬁcant  decreases  in  QRS  duration  and  interventricular
yssynchrony,  and  signiﬁcant  increases  in  contractility,  ejec-
ion  fraction,  and  cardiac  output.  After  a  median  follow-up
f  17.4  months,  RV  fractional  area  of  change  increased  from
8%  prior  to  CRT  to  30%.  However,  no  reduction  in  tricuspid
egurgitation  was  noted  [17].
ong-term pacing
ong-term  CRT  for  systemic  RV  dysfunction  was  ﬁrst
eported  in  case  reports  with  opposing  results.  Zartner  et  al.
escribed  a  positive  impact  with  CRT,  in  terms  of  exercise
erformance  and  brain  natriuretic  peptide  in  a  symptomatic
atient  with  complete  transposition  of  the  great  arter-
es  and  Mustard  operation  [49]. In  contrast,  Kiesewetter
t  al.  reported  negative  results  with  prolonged  CRT  in  three
atients  with  systemic  RV  failure  (one  Mustard  procedure
nd  two  congenitally  corrected  transposition  of  the  great
rteries)  [50]. This  was  despite  an  initial  favourable  result
ith  CRT.
Three  studies  have  analysed  the  long-term  impact  of  CRT
n  patients  with  failing  systemic  right  ventricles.  However,
hey  are  all  observational  studies  that  only  included  small
umbers  of  patients.  Jauvert  et  al.  showed  that  CRT  was
echnically  feasible  and  observed  improvements  in  cardiac
echanical  function  and  clinical  status  in  seven  patients
ho  presented  with  a  failing  systemic  right  ventricle  and
entricular  dyssynchrony  [51]. The  largest  study  to  date  is  a
ulticentre  study  that  included  17  patients  with  systemic  RV
ailure  who  received  CRT  [16]. These  patients  had  a  signiﬁ-
ant  increase  in  systemic  ejection  fraction  and  a  signiﬁcant
ecrease  in  QRS  duration;  and  13  patients  also  had  clinical
mprovement.  In  the  study  conducted  by  Cecchin  et  al.,  nine
atients  with  a  systemic  right  ventricle  underwent  CRT,  but
[[
[
[
[
[
[
[
[
[
[
[
[
[Resynchronization  in  congenital  heart  disease  
only  four  patients  were  felt  to  have  responded  to  therapy  in
the  long  term  [41].
Summary
The  mixed  results  from  these  small,  non-randomized,  non-
controlled  studies  emphasize  the  need  for  further  clinical
research  in  this  area.  Further  acute  studies  may  be  helpful
to  better  characterize  patients  who  show  a  positive  acute
response.  Ultimately,  in  order  to  deﬁnitively  answer  the
question  of  clinical  outcome  in  this  group  of  patients,  large
randomized  multicentre  outcome  studies  would  be  required.
From  a  technical  point  of  view,  the  coronary  sinus  is  usu-
ally  inaccessible  from  the  systemic  veins  in  most  patients
who  have  had  the  Mustard  or  Senning  operation.  They  may
therefore  require  alternative  approaches  to  achieve  CRT.  In
contrast,  coronary  sinus  lead  placement  appears  anatomi-
cally  feasible  in  congenitally  corrected  transposition  of  the
great  arteries.
Conclusions
In  patients  with  CHD,  a  relationship  exists  between  electri-
cal  and  mechanical  dysfunction,  as  well  as  a  link  between
myocardial  remodelling,  rhythm  disturbances,  and  elec-
tromechanical  dyssynchrony.  Depressed  contractility  and
remodelling  may  be  promoted  by  the  presence  of  mechan-
ical  dyssynchrony,  which,  therefore,  may  be  a  desirable
therapeutic  target.  Studies  of  the  safety  and  efﬁcacy  of
CRT  in  patients  with  CHD  are  limited  to  case  reports,
retrospective  analyses  of  heterogeneous  populations,  and
small  crossover  trials  conducted  in  the  immediate  post-
operative  period.  CRT  is  not  currently  recommended  in
international  guidelines  [52]; and  randomized  studies  are
warranted  before  application  of  CRT  in  clinical  practice  in
this  speciﬁc  subset  of  patients.
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